Annual report [Section 13 and 15(d), not S-K Item 405]

Balance Sheet Components (Tables)

v3.25.1
Balance Sheet Components (Tables)
12 Months Ended
Dec. 31, 2024
Balance Sheet Components [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets as of December 31, 2023, and 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2023     2024  
Prepaid directors’ and officers’ liability insurance premiums   $ 270     $ 263  
Prepaid preclinical services     3,103       3,604  
Other     325       939  
Total   $ 3,698     $ 4,806  
Schedule of Property, Plant and Equipment

Property, plant and equipment as of December 31, 2023 and 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2023     2024  
Leasehold improvements   $ 21     $ 49  
Lab Equipment    
             -
      26  
CIP    
-
      10  
Furniture and fixtures     21       29  
Subtotal     42       114  
Less accumulated depreciation     (16 )     (39 )
Net   $ 26     $ 75  
Schedule of Accounts Payable

Accounts payable as of December 31, 2023 and 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2023     2024  
Trade accounts payable   $      821     $       966  
Credit card liability     18       92  
Total   $ 839     $ 1,058  
Schedule of Accrued Liabilities

Accrued liabilities as of December 31, 2023 and 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2023     2024  
Accrued labor costs   $           1,917     $         1,910  
Accrued drug development costs     1,034       1,258  
Other     283       394  
Total   $ 3,234     $ 3,562